IBC Life Sciences, Hilton Boston Logan Airport, Boston, MA
June 6-8, 2005
Through improving the preclinical assessment of drug efficacy, researchers can make product improvements to increase the probability of market success, help streamline clinical trials and identify characteristics of candidates that may result in late stage attrition. As pharmaceutical science evolves, so too does the quality of predictive methods and technologies used for early efficacy assessment. By attending this meeting, you will learn about the state of the art in early efficacy assessment from leading industry and academic researchers and return to your lab with new approaches you can apply immediately to improve your research processes. To register or view full details, visit www.IBCLifeSciences.com/3143, or call +1 508-616-5550 x1004.
|
|